CAAA617A123101 A Phase 1, open-label, multi-center study of radiation dosimetry, safety, and tolerability of extended Lu177 PSMA treatment in chemo-naive adults with metastatic casration-resistant prostate cancer

  • Phase I
  • Trial Category: Genitourinary

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*